Healthcare & Life Sciences
CellMEAT
South Koreathecellmeat.com
CellMEAT is a series a startup based in South Korea. 1 investor tracked.
Activeseries-a
series-a
Stage
2022
Founded
2
Investors
About CellMEAT
CellMEAT is a company founded in 2022 headquartered in South Korea. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
CellMEAT is a biotech company developing cultured meat using plant-based biomass scaffolding and serum-free culture media.
Explore CellMEAT's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.